----
About

Oramed Pharma
ORMP.US
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc.
Profile
- Company Name
- Oramed Pharmaceuticals Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- oramed.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
